Ifosfamide in the management of malignant melanoma: a Southwest Oncology Group Phase II Study.
D001853:Bone Marrow / Q000187:drug effects; D003520:Cyclophosphamide / Q000031:analogs & derivatives*; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage* / Q000009:adverse effects; D008545:Melanoma / Q000188:drug therapy*; D014481:United States
D003520:Cyclophosphamide; D007069:Ifosfamide